Granulocyte colony-stimulating factor therapy for facioscapulohumeral dystrophy: a case report

Journal Title: Progress in Health Sciences - Year 2016, Vol 6, Issue 2

Abstract

We examined the safety and effectiveness of a low dose of analog granulocyte-colony stimulating factor in a 15-year-old boy with facioscapulohumeral dystrophy. The onset of disease was noted at 12 years of age. The physical examination noted general muscle atrophy more pronounced at left side of the body. He was able to walk 300 meters within 6 minute walk test. Granulocyte colony-stimulating factor 5 μg/kg was given subcutaneously daily for 5 days/month for 1, 2, 3, 6 and 12 months. Clinical examination, laboratory tests including blood, biochemical tests, and CD34+ cells were performed. A significant increase of muscle strength in the lower and upper limbs between baseline, and after 3 months of treatment, after 6, and after 12 months was found. He was able to walk 480 meters within 6 minutes after 12 months. Electromyography demonstrated increase of amplitude in the examined in upper and lower limbs after six months compared to baseline. Leukocyte levels remained below 25000/μL. CD34+ increased significantly at day 5 of granulocyte colony-stimulating factor admini-stration. It was safe and well tolerated by the patient. A significant increase in muscle strength in this patient with facioscapulohumeral dystrophy after 3 months of treatment, after 6, and after 12 months since the first treatment course was completed may indicate beneficial effects of granulocyte colony-stimulating factor in this disorder.

Authors and Affiliations

D. Sienkiewicz, W. Kułak, B. Okurowska-Zawada, G. Paszko-Patej, J. Wojtkowski, E. Dmitruk, K. Okulczyk, A. Kalinowska, R. Pogorzelski

Keywords

Related Articles

Fine needle aspiration cytology in the diagnosis of Sjögren’s syndrome

Introduction: Sjögren’s syndrome is an autoimmune disease belonging to the group of collagenases. It is characterized by lymphocytic infiltration of the exocrine glands, leading to their impairment or complete dysfunctio...

The role of different monocyte subsets and macrophages in asthma pathogenesis

Monocytes are comprised of three phenotypically and functionally distinct subsets: classical CD14++CD16-, intermediate CD14++CD16+ and non-classical CD14+CD16++ cells that can play differential roles in regulation of bot...

In the service of hope? Self-awareness of folk healers and their social reception

Purpose: The purpose of this research was to obtain knowledge about the activity of contemporary folk healers from Podlasie from two points of view – the healers themselves and representatives of the local communities. M...

Effects of different cultural background among students studying in an English medical program in Poznan

Introduction: Study abroad offers many benefits as well as challenges; the biggest challenge is cultural shock. Purpose: The purpose of this study is to determine the influence of cultural orientation and its effects on...

Nutritional habits in the elderly

Introduction: Aging is accompanied by several physiological and psychological changes in the organism of an individual (e.g., decreased sense of taste and smell, disruption of satiety, depression), which affect the nutri...

Download PDF file
  • EP ID EP186967
  • DOI 10.5604/01.3001.0009.5165
  • Views 87
  • Downloads 0

How To Cite

D. Sienkiewicz, W. Kułak, B. Okurowska-Zawada, G. Paszko-Patej, J. Wojtkowski, E. Dmitruk, K. Okulczyk, A. Kalinowska, R. Pogorzelski (2016). Granulocyte colony-stimulating factor therapy for facioscapulohumeral dystrophy: a case report. Progress in Health Sciences, 6(2), 175-177. https://europub.co.uk/articles/-A-186967